Why AcelRx Pharma Shares Are Trading Higher Today?
The FDA has recently modified the AcelRx Pharmaceuticals Inc’s (NASDAQ:ACRX) Dsuvia Risk Evaluation and Mitigation Strategies (REMS) requirements for healthcare setting audits. …
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell
• AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Kiromic BioPharma (NASDAQ:KRBP) stock increased by 12.6% to $0.58 during Friday's after-market session. The market value of their outstanding shares is at $8.9 million.
AcelRx Pharmaceuticals Announces Publication Of Clinical Data Finding Potential Benefits Of Nafamostat Compared To Regional Citrate For Anticoagulation Of The Dialysis Circuit
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the
94 Biggest Movers From Friday
Gainers
Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday.
TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9.51.